Mississippi health officials report first 2013 case of West Nile virus

West Nile virus Read More »

Researchers develop novel approach to dengue therapy

Dengue fever Read More »

Atox Bio publishes data on flesh eating bacteria treatment

Atox Bio recently announced new data that shows in an animal model of necrotizing soft tissue infection, the administration of AB103 increases the survival rate. Read More »

New flu vaccine approved for European market

GlaxoSmithKline, a pharmaceutical company, recently announced approval to be the first to market its four-strain seasonal influenza vaccine, marketed as Influsplit Tetra and Fluarix Tetra, in Germany and the UK respectively. Read More »

Varicella vaccine neutralizes chicken pox

Chickenpox Read More »

Inovio Pharmaceuticals receives $3.5 million NIAID grant for mass vaccination device

Inovio Pharmaceuticals, Inc., a Bluebell, Pennsylvania-based vaccine developer, announced on Wednesday that it will receive a $3.5 million grant to advance the development of its next-generation DNA vaccine delivery device. Read More »

WHO notified of influenza A human infection in China

The National Health and Family Planning Commission notified the WHO on April 10 of four laboratory-confirmed cases of human infection with influenza A (H7N9). Read More »

Vaccine for China flu ready for testing

Bioradar UK, Ltd., and Replikins, Ltd., announced on Tuesday that a new synthetic vaccine which protects against the H7N9 avian, or China, flu is ready for testing . Read More »

Genetically engineered smallpox virus may slow liver cancer

Researchers at University of California, San Diego School of Medicine recently started enrolling a clinical trial to test a genetically altered vaccinia virus to slow the progression of liver cancer. Read More »

Shingles vaccine reduces postherpetic neuralgia and herpes zoster

The shingles vaccine is associated with reduction in postherpetic neuralgia and herpes zoster, though uptake of the vaccine in the U.S. is low, according to a recent study published in PLOS Medicine. Read More »

FDA requests budget of $4.7 billion to ensure food safety

The U.S. Food and Drug Administration has requested a budget of $4.7 billion to protect and promote the public health as part of the 2014 budget. Read More »

Inovio Pharmaceuticals outlines plans for new vaccine delivery technology

Inovio Pharmaceuticals, Inc., detailed its plans on Tuesday for a device that will be able to simultaneously administer multiple synthetic vaccines. Read More »

Hawaii Biotech acquires WNV technology from Merck

Hawaii Biotech, Inc., a Hawaii-based biotechnology company, announced on Thursday the acquisition of a West Nile virus vaccine technology patent family and a non-exclusive license to recombinant protein expression technology from a Merck subsidiary. Read More »

Florida Department of Health monitors H7N9 bird flu outbreak in China

Influenza A Read More »

CVS Caremark helps commercial clients save money on pharmaceuticals

CVS Caremark released its annual Insights report Thursday, stating that its distribution of generic drugs saved commercial clients 3.6 percent on traditional medications. Read More »

GenScript responds to H7N9 Avian Flu

GenScript was the fastest biotech company to complete a synthetic key to the H7N9-related gene on April 5, four days after hearing of the avian flu. Read More »

Study: Current HPV vaccine may not help immune-compromised women

HPV Read More »

Minnesota reports 10 percent increase in STDs in 2012

Gonorrhea Read More »

WHO endorsed treatment may result in drug-resistant Tuberculosis

Tuberculosis Read More »

Oral insulin candidate awaits FDA research approval

Oramed Pharmaceuticals, Inc., announced on Thursday that it has submitted a new Investigational New Drug application with the FDA for ORMD-0801, an oral insulin candidate. Read More »